Abstract
We propose a general framework for prediction of predefined tumor classes using gene expression profiles from microarray experiments. The framework consists of 1) evaluating the appropriateness of class
prediction for the given data set, 2) selecting the prediction method, 3) performing cross-validated class prediction, and 4) assessing the significance of prediction results by permutation testing. We
describe an application of the prediction paradigm to gene expression profiles from human breast cancers, with specimens classified as positive or negative for
Get full access to this article
View all access options for this article.
